United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 4 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Arcellx, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | |||
|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -53.42% | -3% | -3.68% | -4.15% | -4.63% |
|---|---|---|---|---|---|
| ROA | -34.81% | -1.9% | -2.11% | -2.14% | -2.13% |
| Gross Margin | 100% | 88.5% | 88.4% | 88.11% | 88.15% |
| Total Assets | $603,990.00K | $645,888.24K | $691,138.34K | $740,008.45K | $792,788.16K |
| Net Income | -$228,934.00K | -$11,883.14K | -$14,101.10K | -$15,305.94K | -$16,346.32K |